Featured Health & Pharmaceuticals Actavis launches Gemcitabine on patent expiry in EU markets March 13, 20092 min read The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone Read More Share
